Skip to content
10-Q

Quarterly Report

Revolution Medicines, Inc. RVMD RVMDW

0000950170-25-104022

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 186.93M sh
Shares Diluted Q2 2025 · Jun 30, 2025 188.58M sh
Shares Diluted Q2 2025 · Jun 30, 2025 188.37M sh
Shares Diluted Q2 2025 · Jun 30, 2024 165.14M sh
Shares Diluted Q2 2025 · Jun 30, 2024 164.94M sh
Capex Q2 2025 · Jun 30, 2025 $10.72M
Capex Q2 2025 · Jun 30, 2024 $5.57M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$416.19M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$288.73M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $402.44M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $543.06M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $275.71M
Stockholders Equity Q2 2025 · Jun 30, 2025 $1.87B
Stockholders Equity Q2 2025 · Mar 31, 2025 $2.08B
Stockholders Equity Q2 2025 · Dec 31, 2024 $2.27B
Stockholders Equity Q2 2025 · Jun 30, 2024 $1.62B
Stockholders Equity Q2 2025 · Mar 31, 2024 $1.73B
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.83B
Current Liabilities Q2 2025 · Jun 30, 2025 $184.53M
Current Liabilities Q2 2025 · Dec 31, 2024 $163.91M
Total Liabilities Q2 2025 · Jun 30, 2025 $564.2M
Total Liabilities Q2 2025 · Dec 31, 2024 $293.1M
Current Assets Q2 2025 · Jun 30, 2025 $2.18B
Current Assets Q2 2025 · Dec 31, 2024 $2.33B
Total Assets Q2 2025 · Jun 30, 2025 $2.43B
Total Assets Q2 2025 · Dec 31, 2024 $2.56B
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.31
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.45
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.81
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.51
Eps Basic Q2 2025 · Jun 30, 2025 −$1.31
Eps Basic Q2 2025 · Jun 30, 2025 −$2.45
Eps Basic Q2 2025 · Jun 30, 2024 −$0.81
Eps Basic Q2 2025 · Jun 30, 2024 −$1.51
Sga Expense Q2 2025 · Jun 30, 2025 $40.58M
Sga Expense Q2 2025 · Jun 30, 2025 $75.59M
Sga Expense Q2 2025 · Jun 30, 2024 $21.71M
Sga Expense Q2 2025 · Jun 30, 2024 $44.55M
Rd Expense Q2 2025 · Jun 30, 2025 $224.13M
Rd Expense Q2 2025 · Jun 30, 2025 $429.88M
Rd Expense Q2 2025 · Jun 30, 2024 $134.93M
Rd Expense Q2 2025 · Jun 30, 2024 $252.95M
Net Income Q2 2025 · Jun 30, 2025 −$247.79M
Net Income Q2 2025 · Jun 30, 2025 −$461.2M
Net Income Q2 2025 · Mar 31, 2025 −$213.42M
Net Income Q2 2025 · Jun 30, 2024 −$133.23M
Net Income Q2 2025 · Jun 30, 2024 −$249.24M
Net Income Q2 2025 · Mar 31, 2024 −$116M
Operating Income Q2 2025 · Jun 30, 2025 −$264.71M
Operating Income Q2 2025 · Jun 30, 2025 −$505.47M
Operating Income Q2 2025 · Jun 30, 2024 −$156.64M
Operating Income Q2 2025 · Jun 30, 2024 −$297.5M